Risk of major bleeding during the at-risk period was also similar in rivaroxaban-treated and warfarin-treated participants ( @ % versus @ % per @ days ; hazard ratio -LSB- confidence interval -RSB- = @ -LSB- @-@ @ -RSB- ; P = @ ) .